Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Hoare

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Diabetes|August 25, 2025
Glucagon Receptor Deficiency Causes Early-Onset Hepatic SteatosisTessa M Cacciottolo, Katherine Lawler, Kevin M Méndez-Acevedo, et al.
Genome Medicine|June 23, 2022
Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver diseaseGabriella Assante, Sriram Chandrasekaran, Stanley Ng, et al.
Journal of Hepatology|April 23, 2023
Hepatocytes undergo punctuated expansion dynamics from a periportal stem cell niche in normal human liverAdam M Passman, Magnus J Haughey, Emanuela Carlotti, et al.
Metabolism: Clinical and Experimental|March 24, 2025
Spatial lipidomics reveals sphingolipid metabolism as anti-fibrotic target in the liverAleksandra Gruevska, Jack Leslie, Elena Perpiñán, et al.
Science Immunology|July 19, 2024
Cross-talk between ILC2 and Gata3<sup>high</sup> T<sub>regs</sub> locally constrains adaptive type 2 immunityJulie Stockis, Thomas Yip, Julia Moreno-Vicente, et al.
Journal of Hepatology|July 6, 2025
Somatic loss-of-function mutations in CIDEB reduce hepatic steatosis by increasing lipolysis and fatty acid oxidationQiyu Zeng, Satish Patel, Xun Wang, et al.
Nature|October 14, 2021
Convergent somatic mutations in metabolism genes in chronic liver diseaseStanley W K Ng, Foad J Rouhani, Simon F Brunner, et al.
EMBO Molecular Medicine|August 21, 2024
Novel immunotherapeutics against LGR5 to target multiple cancer typesHung-Chang Chen, Nico Mueller, Katherine Stott, et al.
Nature|February 19, 2025
Human-correlated genetic models identify precision therapy for liver cancerMiryam Müller, Stephanie May, Holly Hall, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Diabetes|August 25, 2025
Glucagon Receptor Deficiency Causes Early-Onset Hepatic SteatosisTessa M Cacciottolo, Katherine Lawler, Kevin M Méndez-Acevedo, et al.
Genome Medicine|June 23, 2022
Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver diseaseGabriella Assante, Sriram Chandrasekaran, Stanley Ng, et al.
Journal of Hepatology|April 23, 2023
Hepatocytes undergo punctuated expansion dynamics from a periportal stem cell niche in normal human liverAdam M Passman, Magnus J Haughey, Emanuela Carlotti, et al.
Metabolism: Clinical and Experimental|March 24, 2025
Spatial lipidomics reveals sphingolipid metabolism as anti-fibrotic target in the liverAleksandra Gruevska, Jack Leslie, Elena Perpiñán, et al.
Science Immunology|July 19, 2024
Cross-talk between ILC2 and Gata3<sup>high</sup> T<sub>regs</sub> locally constrains adaptive type 2 immunityJulie Stockis, Thomas Yip, Julia Moreno-Vicente, et al.
Journal of Hepatology|July 6, 2025
Somatic loss-of-function mutations in CIDEB reduce hepatic steatosis by increasing lipolysis and fatty acid oxidationQiyu Zeng, Satish Patel, Xun Wang, et al.
Nature|October 14, 2021
Convergent somatic mutations in metabolism genes in chronic liver diseaseStanley W K Ng, Foad J Rouhani, Simon F Brunner, et al.
EMBO Molecular Medicine|August 21, 2024
Novel immunotherapeutics against LGR5 to target multiple cancer typesHung-Chang Chen, Nico Mueller, Katherine Stott, et al.
Nature|February 19, 2025
Human-correlated genetic models identify precision therapy for liver cancerMiryam Müller, Stephanie May, Holly Hall, et al.
Pageof 5